CDC has announced its upcoming announcement of new incidence numbers that will show that rates of HIV in the United States are higher than previously estimated. Their "Dear Colleague" letter is below:
July 22, 2008
Dear Colleague:
The Centers for Disease Control and Prevention (CDC) is preparing for
the release of HIV incidence estimates for the United States from the
first national HIV incidence surveillance system of its kind in the
world. These new incidence estimates are based on direct measurement of
new HIV infections and will provide the clearest picture to date of
incidence (or the number of new HIV infections in a given year). These
more precise estimates are possible now only because of breakthrough
technology developed by CDC that can distinguish recent from
long-standing HIV infections.
As many of you are aware, CDC has been working for several years to
plan, establish and evaluate this critical surveillance system. Once
the surveillance system was mature enough to produce incidence
estimates, it was imperative for these estimates to receive rigorous
scientific review. This process took longer than we anticipated, but,
in the end, it has produced estimates that are more reliable and
scientifically sound than would have occurred without the independent
review.
The manuscript containing the estimates has been accepted for
publication by the Journal of the American Medical Association (JAMA)
and is scheduled to be released on August 3, 2008. To prepare for the
upcoming release of new HIV incidence estimates, CDC has developed a
fact sheet on HIV/AIDS surveillance, available at http://www.cdc.gov/hiv/topics/
CDC will send another Dear Colleague letter and fact sheet on the new
HIV incidence estimates immediately upon their release. Additionally, a
series of briefings are planned to keep prevention partners and
practitioners informed about the estimates and their significance to
HIV prevention in the United States. An advisory will be sent to you
before these estimates are released alerting you of the impending
release, advising you about briefing times, and indicating where you
can access Web-based resources and materials. Please stay tuned for
detailed information in the coming weeks and thank you for all that you
do in support of HIV prevention.
Sincerely,
Richard Wolitski, Ph.D.
Acting Director,
Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral
Hepatitis, STD and TB Prevention
